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ABSTRACT 
Objective: The quality of the embryo is greatly influenced by the quality of the oocytes; oocyte-secreted factors (OSFs), which include GDF-9 and 
BMP-15, play an important role in folliculogenesis. This study was to determine the relationship between GDF-9 and BMP-15 serum within the 
follicular fluid in order to predict the quality of oocytes in women undergoing In vitro Fertilization (IVF).  
Methods: We collected 30 samples of blood serum and 30 samples of follicular fluid on the day of ovum pickup (OPU), and examined GDF-9 and 
BMP-15 using ELISA kits. Analysis by Pearson and a partial-correlation was conducted to analyze the correlation between the concentration of GDF-
9 and BMP-15 in serum and follicular fluid with general physiological parameters, such as maturation and fertilization rates.  
Results: The mean age of the subjects was 35,0(26,0-39,0) years. There was no statistical correlation between GDF-9 serum and follicular fluid 
(p=0.245); but there was a correlation between BMP-15 serum and follicular fluid (p=0.001). Average level of GDF-9 in the follicular fluid was 163,0 
pg/ml (48,0-537), and average level in the serum was 260.33 pg/ml±121,82; average levels of BMP-15 in the follicular fluid was 58.30pg/ml±31,54 
and average levels of BMP-15 in the serum was 74.20 pg/ml (1,0–610).  
Conclusion: There were no correlations between levels of GDF-9 serum-FF and BMP-15-FF, and maturation rates and fertilization rates. There was 
a negative correlation between BMP-15 serum and maturation rates.  
Keywords: BMP-15, Fertilization rate, Follicular fluid, GDF-9, Maturation rate  




IVF is a procedure wherein fertilization of the egg cell by the sperm is 
accomplished outside the body in vitro as an alternative method in 
infertility cases where other methods were unsuccessful [1]. Reasons 
for IVF include abnormalities of the fallopian tubes, unexplained 
infertility (idiopathic), male infertility, endometriosis and infertility 
due to cervical factors or immunological and hormonal disorders [2, 
3]. According to the Society for Assisted Reproductive Technology, 
data show that 11% of couples of reproductive age experience 
infertility, and approximately 10% of such cases require IVF with an 
average gestation of 21.3% and a birth-rate of 33.1% [4, 5]. Based on 
this report, Indonesian women who underwent IVF in 2018 achieved 
pregnancy rates of 29.05%. Since the birth of the first IVF baby on July 
25, 1978, IVF has become the most often-used assisted reproductive 
technology (ART) program, but the IVF process is not easy for couples 
and yields low success rates [1-5]. 
The quality of the embryo is greatly influenced by the quality of the 
oocytes; oocytes that are of poor quality can be the cause of 
infertility in women and a major obstacle to success with the IVF 
program. Several factors have been used as parameters to assess 
oocyte quality; the morphology parameters have much in used to 
search for a marker of the oocyte quality that can provide better 
potential for the development of the embryo. 
A disadvantage of this system is the multiplicity of methods used in 
different studies, which sometimes leads to controversial results. 
Some research indicates a significant relationship between the 
morphology of the oocyte and the quality of the embryo, while other 
studies do not show a meaningful relationship. This is due to the 
nature of an assessment that is subjective and depends on which 
method embryologists use [5-12]. 
Assessments of oocyte maturation still use a combination of 
methods for monitoring the nucleus and the cytoplasm. However, 
this raises a question as to the presence of other factors that play a 
role in the rate of oocyte maturation; factors to consider are Anti-
Müllerian hormones (AMH), GDF-9 and BMP-15. Several of the 
endocrine markers for reproductive function are used to manage 
infertility and estimate potential fertility. Follicle-stimulating 
hormones (FSH), oestradiol (E2) and AMH are the markers in 
ovaries that are monitored to assess the likely magnitude of the 
ovarian response to gonadotropin stimulation during ART, as they 
provide an indication of the amount of follicular growth in the 
ovaries. Some of these markers only offer an estimate of ovarian 
reserve, but no information of ‘oocyte quality’, which has an impact 
on limitations related to the fertility of women. BMP-15 and GDF-9 
are markers that indicate the function and quality of the oocytes; 
both are mostly secreted by the oocyte and play an important role in 
the development of oocytes and the fertility of mammals. BMP-15 
and GDF-9 are considered to be factors that are secreted paracrine 
by oocytes and act in the follicles of the ovaries to regulate the 
signaling and communication of cells around the oocyte (somatic 
cells) (i.e., granulosa and cumulus cells that regulate folliculogenesis 
and fecundity). BMP-15 is an important factor for reproduction in 
mono-ovular species such as humans and sheep, but not in a poly-
ovular species like a rat. GDF-9 is very important for the fertility of 
mammals in both mono-and poly-ovular species, and mutations that 
lead to inactivation of the GDF-9 genes result in infertility in sheep 
and rats [6-14]. 
GDF-9 and BMP-15 are members of the superfamily of transforming 
growth factors (TGF) and are secreted from the oocyte during the 
folliculogenesis process. Both are very important for folliculogenesis 
and female fertility. Diminishing GDF-9 will cause a decrease in the 
proliferation of granulosa cells, resulting in abnormal oocyte growth 
and failure of the follicles to develop beyond the primary stage; GDF-
9 also inhibited apoptosis of granulosa cells and atresia of ovarian 
follicles. BMP-15 stimulates the mitosis and proliferation of 
granulosa cells; mutation of BMP-15 in women leads to ovarian 
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hypergonadotropic. Both will inhibit the secretion of progesterone 
in the end of the follicular phase. Additionally, the oocytes regulate 
the proliferation of cumulus cells, apoptosis, metabolism and 
expansion by secreting these two factors paracrine [4–6, 13–32]. 
Granulosa cells that are directly exposed to the oocyte during the 
development of follicle and ovulation appear to regulate oocyte 
development and fertilization and are governed by the oocyte factors. 
GDF-9 can inhibit premature secretion of progesterone, the formation 
of receptor LH and the synthesis of cyclic adenosine monophosphate. 
GDF-9 is the main medium that is secreted by the oocyte, which can 
stimulate expansion of cumulus cells. In a previous study in patients 
with polycystic ovary syndrome, even though ovulation stimulation 
sparks the growth of follicles, the expression of GDF-9 in granulosa 
cells remains lower than the normal value, which can cause premature 
luteinization and decrease oocyte development; this may be related to 
the high rate of miscarriage [8, 9, 12, 33–38]. 
Assessment of GDF-9 and BMP-15 can be done through the 
expression of mRNA in granulosa cells, concentrations in the serum 
and follicular fluid. Although assessment of concentrations of GDF-9 
and BMP-15 in the serum is still limited, but from study by 
Riepsamen et al.; the concentration levels of GDF-9 and BMP-15 can 
already be detected in the serum of women who undergo an IVF 
course in Australia with the use of monoclonal antibodies as the 
epitope of the GDF-9 and BMP-15 proteins so that the markers can 
also be checked through an examination of their respective levels in 
serum such as AMH [6]. As to the presence of BMP-15 and GDF-9 in 
serum, they should be exempt from the proteoglycan-binding 
granulosa/cumulus extracellular matrix (ECM) transit through the 
basal lamina of the follicle and migrates puzzle to the ECM to enter 
into the blood vessels. The TGFß superfamily plays an important 
role in controlling the growth-factor mechanism that transits 
through the ECM, although it is unclear how this is related to BMP-
15, GDF-9 and AMH. Therefore, the magnitude of the BMP-15 and 
GDF-9 serum may depend on the regulation of the ECM, gap 
junctions and capillary leakage, so the levels are similar in the 
ovaries. The presence of specific proteins in the serum represents a 
potential target in the examination of female fertility. If the levels of 
AMH serum can determine the reserve of oocytes in the ovaries, 
then GDF-9 and BMP-15 serum can be a marker of the quality of the 
oocyte. In the course of examining the concentration of GDF-9 and 
BMP-15 follicular fluid, there have been studies that show the 
relationship between the concentration of GDF-9 and BMP-15 in 
follicular fluid with the oocyte quality [6–8, 39–49]. 
Assessment of the quality of the oocytes will be seen from the 
maturation of oocytes (either the nucleus, cytoplasm and the 
morphology of the polar bodies) and the rate of fertilization has 
been known as a predictor of fertilization of oocytes and quality of 
embryos after intracytoplasmic sperm injection (ICSI). In their 
research, xia viewed the three factors—namely the polar bodies, 
space perivitelline and body inclusions in the cytoplasm—to assess 
the quality of oocytes based on the morphological criteria outlined 
by Veeck (1990) [50–64]. 
Furthermore, in IVF, the rate of fertilization is commonly used to 
measure how many oocytes were fertilized by a sperm; normal 
fertilization is identified by the presence of two pronuclei (2pn) at 
the time of the fertilization assessment (i.e., 16 h to 19 h after ICSI 
or conventional insemination). The rate of fertilization is a 
predictor, which is also a good estimate of the success of the 
implantation. 
The aim of this study is to determine the relationship between the 
levels of GDF-9 and BMP-15 serum with the levels of follicular fluid 
to predict the quality of oocytes (i.e., oocyte maturation rates and 
fertilization rates) in women who are undergoing IVF. 
MATERIALS AND METHODS 
This study was approved by the Committee of Health Ethics of our 
university in September 2019. All subjects signed informed consent. 
A descriptive-analytic study using the designed cross-sectional study 
was performed at the Centre of Reproductive Medicine in the 
hospital of our university (Yasmin Clinic). In total, 30 women who 
underwent the IVF procedure with short protocol for ovarian 
stimulation and ICSI participated in this study. 
Women IVF candidates were 20–40 y of age, were willing to engage 
in this study and were undergoing an IVF course. Exclusion criteria 
included patients with polycystic ovarian syndrome and/or 
endometriosis who had not attained oocyte maturation, and for 
whom the IVF procedure had been postponed. Demography data of 
the patients is presented in table 1.  
All subjects underwent the protocol for ovarian stimulation. Blood 
samples were taken to determine basal levels of endocrine hormones 
during the menstrual cycle. Endocrine hormones such as FSH, LH and E2 
were measured using an Axsym Chemiluminescence Detection System 
(Axsym; Abbott Laboratories, Rungis, France). The regimen of 
stimulation is Gonadotropin (Gonal-f, 150–300 IU; Merck Serono, 
Darmstadt, Germany) that was subcutaneously injected for ovarian 
induction on days 2–3. The regimen of hCG, 10,000 IU (Ovidrel; Merck 
Serono) was intramuscularly injected when the diameter of a minimum 
of three dominant follicles was at least 18 mm. Blood samples of 5 cc of 
blood were collected before ovum retrieval and entered into a serum 
separator tube, then brought to the integrated laboratory in our faculty. 
Where the serum samples were standing for two hours until they 
solidified at room temperature, centrifuged 1000 rpm at a temperature 
of 2–8 °C, and then stored for 3–4 w at a temperature 4 °C; the 
supernatant was saved for analysis of GDF-9 and BMP-15. After the 
ovum retrieval process, embryologists took the intrafollicular fluid and 
sent it to the laboratory, where the GDF-9 and BM-15 levels were 
examined using ELISA kits. 
Examination of the serum and the follicular fluid was performed 
with the sandwich ELISA principle technique for the ELISA kits, in 
which the plate is precoated with specific antibodies for human GDF-
9 (mab 72 b) and human BMP-15 (mab 28 a) with the specifications 
of the reagent/kit (GDF-9 and BMP-15), sensitivity of 0.1 ng/ml and 
detection range of 0.16–10 ng/ml. The specificity of this kit has been 
recognized for a sample of GDF-9; there are no cross-reaction or 
disorder in human or the other substances. 
The principle works thus: the sample (serum/follicular fluid) or the 
standard is added into the micro-ELISA plate and combined with specific 
antibodies. It is then biotinylated with antibodies to human GDF-9 and 
BMP-15, and conjugation of avidin-horseradish peroxidase (HRP) is 
added onto each microplate then incubated. Components free 
components the other will be leached, and the substrate liquid is added 
into each of the tubes/wells. Only wells that contained GDF-9/BMP-15 
that their antibodies were biotinylated and avidin-HRP which will emit a 
blue color. The reaction of the enzyme substrate is terminated by adding 
a stop solution that will turn into a yellow color. Optical density 
spectrophotometer used for the measurement with a wavelength of 450 
nm 2 nm where the optical density is proportional to GDF-9/BMP-15. 
The concentration of human GDF-9 and BMP-15 can be calculated by 
comparing the optical density of the sample against the standard. 
Oocytes from OPU are inspected and analyzed by embryologists at the 
laboratory of our hospital’s IVF clinic to assess the degree of 
morphological oocytes. 
The maturation of oocytes is examined under an inverted microscope. 
If a first polar body is observed in the oocyte cytoplasm, the oocyte is 
considered to be in the metaphase II (MII) stage; the oocyte 
maturation rate refers to the number of MII oocytes divided by the 
total number of all oocytes at OPU. Regarding the rate of fertilization, 
normal fertilization is identified by the presence of two pronuclei 
(2pn) at the time of the fertilization assessment (i.e., 16 h to 19 h after 
ICSI); the fertilization rates refer to the number of fertilization oocytes 
divided by the total number of all oocytes at OPU. 
Statistical analysis 
The normal distribution of all data was examined by the 
Kolmogorov-Smirnov test, and the data in the tables are shown as 
means±standard deviation (SD). The correlation between the level 
of GDF-9 and BMP-15 serum and follicular fluid with several 
physiological parameters (age, BMI, etc.) was analyzed with the 
Pearson and Spearman correlation coefficient. The correlation 
between GDF-9 and BMP-15 levels and oocyte developmental 
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(maturation rates and fertilization rates) was used for partial 
analysis. After adjusting for the number of retrieved oocytes, the 
comparison of GDF-9 and BMP-15 levels in different groups were 
used for a covariance analysis by linier regression. Data analysis was 
conducted with the Statistical Program for Social Sciences (SPSS) 
version 20.0, and statistical significance was considered at P<0.05. 
RESULTS 
Our result showed that the mean age of the subjects was 35,0(26,0-
39,0) years and the mean duration of infertility of the subjects was 
6.6±5,31 y. The characteristics/descriptives of the subjects are given 
in table 1. 
  
Table 1: The characteristics/descriptives of the subjects 
Characteristic n=30 
Age (year) 35,0 (26,0-39,0) 
Duration of infertlity (year) 6,6  5,31 
BMI 24,00(18,8-35,6) 
Number of oocytes retrieved 11,06  7,49 
Number of mature oocyte 8,46  6,54 
Maturation rate (%) 75,0(40-100) 
Fertilization rate (%) 65,2 29,3 
GDF-9 follicular fluid (pg/dl) 163,0(48,0-537) 
GDF 9 serum (pg/ml) 260,63121,82 
BMP-15 follicular fluid(pg. ml) 58,3031,54 
BMP-15 serum (pg/ml).  74,0(610,0-1,0) 
  
There were abnormally distributed data (Shapiro-wilk) test for 
normality, P<0.05) for GDF-9 (follicular fluid), BMP-15 (serum), 
maturation rate and age; and there were normally distributed for 
GDF-9 (serum), BMP-15 (follicular fluid) and fertilization rate.  
Table 2 shows the prediction of GDF-9 and BMP-15 follicular fluid 
levels, GDF-9 and BMP-15 serum levels as the oocyte quality 
parameter. There was no significant correlation between GDF-9 
serum and FF (P>0,05) but there was a significant correlation BMP-
15 serum and follicular fluid (P<0,05). 
After a bivariat analysis of the data with linear regression, there was 
a correlation between BMP-15 serum–FF, GDF-9 serum and BMI 
with maturation rate. While there was a correlation between GDF-9 
serum, BMP-15 serum–FF and age with fertilization rate. The result 
from correlation analysis were given in table 4. 
 
Table 2: Correlation of GDF-9 and BMP-15 in follicular fluid and serum 
 GDF-9 FF BMP-15 FF 
GDF-9 serum p=0,245 r=0,219  
BMP-15 serum  p=0,001 r=0,568 
P = significance. r = correlation coefficient 
 
Table 3 showed the correlation of GDF-9 serum and FF and BMP-15 serum and FF with maturation and fertilization rate. 
 
Table 3: The correlation of gdf-9 in serum and gdf-9 in follicular fluid with the rate of maturation and the rate of fertilization as well as 
the correlation of bmp-15 in serum and bmp-15 in follicular fluid with the rate of maturation and the rate of fertilization 
 Maturation rate(sig.) Fertilization rate (sig.) 
GDF-9 FF p = 0,321. r=0,188 p = 0,307 r= 0,193 
GDF-9 serum p = 0,336 r=0,182 p = 0,633. r= 0,091 
BMP-15 FF p = 0,415. r=0,155 p = 0,365. r= 0,172 
BMP-15 serum p = 0,001 r=-0,577  p = 0,140. r= 0,276 
P= significance. r = correlation coefficient 
After a bivariate analysis of the data with linier regression, there was correlation between BMP-15 serum–FF, GDF-9 serum and BMI with 
maturation rate. While there was a correlation between GDF-9 serum, BMP-15 serum–FF and age with fertilization rate. The result from correlation 
analysis were given in table 4. 
 
Table 4: Multivariate analysis between maturation rates, fertilization rates and BMP-15 serum, age dan BMI 
  Maturation rates   Fertilization rates  
 ß CI 95% p ß CI 95% p 
BMP-15 fol 0,001 (0,002-0,004) 0,489 0,008 (-0,004-0,004) 0,154 
BMP-15 serum 0,001 (-0,002-0,000) 0,007 0,001 (0,000-0,002) 0,119 
GDF-9 fol 0,000 (0,000-0,001) 0,119 0,001 (0,000-0,001) 0,125 
GDF-9 serum 0,000 (-0,001-0,000) 0,283 0,001 (0,000-0,001) 0,167 
Age 0,013 (-0,034-0,008) 0,202 -0,031 (-,060-0,003) 0,031 
BMI 0,002 (0,020-0,024) 0,868 0,012 (0,018-0,042) 0,401 
CI 95%: confidential interval, P: significance, ß: beta 
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DISCUSSION 
The aim of this research is to develop and measure GDF-9 and BMP-
15 in follicular fluid and serum analysis and diagnostic potential in 
reproductive medicine. According previous studies it is known that 
as oocyte-secreted factors, GDF-9 and BMP-15 concentrations were 
very essential for fertility including in humans, where both of these 
factors are considered as factors with autocrine or paracrine 
secreted oocyte which acts in the ovarian follicles to regulates the 
function of cells around the oocyte were granulosa cells and cumulus 
cells as folliculogenesis and fecundity regulators [6, 12]. GDF-9 and 
BMP-15 have homology in high degrees of amino acid and protein 
structure, seem at an overview of expression and function and also 
the interaction of both. These factors were a potent regulator of 
granulosa cells and cumulus cells function to improve the quality of 
oocyte. GDF-9 has the effect of anti-apoptosis on the stage of 
preantral and early follicle, stimulates the proliferation of granulosa 
cells. BMP-15 also has the ability to increase the proliferation of 
granulosa cells and very effective as anti-apoptosis in cumulus cells, 
stimulates the expression of several other proteins such as EGF, 
which esensial for the expansion of cumulus cells. It certainly plays 
an essential role on the stage of cell proliferation, apoptosis process, 
luteinization, and expansion of the cumulus cells metabolism [6, 12, 
34–38]. 
Based on the role of both these factors on the quality of oocytes 
(maturation rate and fertilization rate) our study want to see 
whether the concentration of both these factors can be used a 
marker of quality of the oocyte. In our study the distribution of GDF-
9 and BMP-15 were detected on both follicular fluid and serum, whe 
on the previous study it is known that GDF-9 and BMP-15 
concentration levels were low in serum even only detected in 29% 
of subjects (GDF-9) and 61%(BMP-15).6 But the results of our study 
were surprising because have a high variation and the concentration 
levels in the serum were higher than in the follicular fluids. This may 
be a result of follicular fluid sampling that was conducted by pooling, 
which caused the results obtained to look smaller than serum due to 
dilution process, but some of the previous studies that take a single 
mature follicle also shows a high variation in the level of 
concentration of GDF-9 and BMP-15 in follicular fluid [36–38]. The 
other possibilities were reagen spesivity in KIT, indeed this reagent 
is only specific to examination of serum, plasma and body fluids, so 
no specific mention of the follicular fluid of the ovaries. Also, it could 
be possible the existence of cross-reactivity of monoclonal 
antibodies of the reagent with a substance wich analogous to the 
GDF-9 in the serum is higher compared to the cross reactivity in the 
follicular fluid wich is pure only binds to the GDF-9 [6]. It was also 
obtained in a study by Riepsamen et. al (2019) [6], obtained levels of 
GDF-9 were high in he srum of postmenopausal women, it was 
thought possible consequences there were other cell types that 
express GDF-9 and contributes to detection of the levels of this 
protein in peripheral serum such as the cells of the granulosa and 
cumulus cells, adrenal and other celss [6, 12, 46–49]. Fortunately, we 
can determine the concentration levels of all the samples from the 
serum, so than in the future the examination level of GDF-9 or BMP-15 
follicular fluid can be replaced with serum examination. GDF-9 and 
BMP-15 serum does not appear to significantly decrease with age in 
women of reproductive age (20–40 y). Though as GDF-9 and BMP-15 
are generally considered to be oocyte-specific products and the 
number fall with age. Although the magnitude of the variation in 
serum/follicular fluid GDF-9 and BMP-15 between individual subject, 
the concentration appears to be constant in the subject and are not 
affected by superovulation induction with gonadotropins. BMP-15 and 
GDF-9 may be present in serum must be freed from being tied to the 
granulosa/cumulus extra-cellular proteoglycan matrix and then 
transit in the follicular basal lamina then migrate to the theca 
extracellular matrix (ECM) to enter into blood vessel [13, 15, 34]. 
Distribution of BMP-15 in follicular fluid average 58,30 
pq/ml±31,539 (normal distribution) and BMP-15 serum levels was 
74,0 pq/ml(1,0–610,0) (abnormal distribution), it turns out that 
there was a positive correlation between the level of BMP-15 FF and 
BMP-15 serum (P = 0,001); thus it can be said that the concentration 
of BMP-15 serum was represented the concentration/levels of BMP-
15 follicular fluid. 
GDF-9 and BMP-15 are all factors secreted by the oocyte (OSF) is a 
very important factor in determining the quality of the oocyte, 
where these two factors are very instrumental in the process of 
follikulogenesis especially in the case of constant two-way 
communication between cells-cells that surround the oocyte with 
oocyte itself, both as a means of transfer of nutrients and signal 
paracrine, which of course largely determines the development of 
compartment follicular, maturation of the oocyte and the ability of 
the acquisition of the oocyte to fertilization. An oocyte prior to 
become an oocyte which is competent to achieve miosis complete 
(from prophase i until it's metaphase ii) and are capable for 
fertilization by a sperm to produce embryos that viabel, begins at the 
moment of antral follicles then the complex cumulus (COC) 
contribute to provide the benefits of metabolic and maintain a phase 
of miosis for the growth of the oocyte. at the same time oocyte 
secreted factor (OSF) mediate the metabolism, maturation and 
persistence of complex cumulus (COC). in some previous research, it 
is known that the levels of GDF-9 and BMP-15 are positively 
correlated to the rate of maturation and the rate of fertilization even 
the birth of life, which could be assumed as a representation of the 
quality of the oocyte [37–50].  
The results from several previous study showed that GDF-9-BMP-15 
concentration may be useful to predict the number of good oocyte 
quality in an IVF and also for detecting potential poor responders’ 
patients. But in our study, there was no correlation between GDF-9 
and BMP-15 follicular or serum with maturation rate or fertilization 
rate. However, in our study, from measurements of the levels of 
GDF-9 in serum, GDF-9 in follicular fluid bmp-15 in follicular showed 
no relationship/correlation to the maturation and fertilization rate, 
even obtained the existence of a negative correlation between bmp-
15 serum with the maturation rate. Although the role of GDF-9 and 
BMP-15 in vivo are very good role since the preantral to the oocyte 
mature and its role in folliculogenesis, the development of the 
follicles, anti-apoptosis and the role of communication in two 
directions between the oocytes with the complex of cumulus (COC) 
but the possibility of other factors also need to be examined to 
determine the significantly affect the quality of oocytes, in this case 
seen mainly through the maturity of the oocyte. We did not find a 
direct relationship between individual FF or serum GDF-9 or BMP-
15 level and oocyte developmental competence. In our study, 
individual FF or serum GDF-9 or BMP-15 concentration was quite 
variable, but it does not seem to reflect oocyte fertilisability or 
subsequent embryo quality; this non-association could partly be 
explained by our study samples, where FF was collected by pooling 
or FF was collected from fully matured follicle and the oocyte was 
already fully-matured [52, 57, 63]. 
BMP-15 is a marker of the quality of the oocyte, which affects the 
physiology and growth of follicles. In granulosa cells this protein 
also functions as a growth factor of in a functional oocytes regulation 
of proliferation and differentiation. In addition, it affects the 
development of the granulosa cells layer–oocytes (the cumulus 
layer), so its levels suggest have a positive correlation with 
maturation or fertilization rate, but from our result of BMP-15 
serum that showed a negative correlation with maturation rate 
(coefficient correlation-0,577, P = 0.001), it is possible due to high 
variation of data and the limited sample number/quantities. 
Likewise, the other correlation from GDF-9 serum or FF and BMP-15 
FF were showed no correlation with maturation rate and 
fertilization rate even though from previous research was suggest 
that GDF-9 and BMP-15 act synergistically to promote the ovulation 
of the oocyte surrounded by granulosa cells [55, 56]. 
From the review some other factors that we can see its influence by 
multivariate analysis, where the average age on the subject of this 
study was 35 y (26,0-39,0) and having performed a statistical test to 
see its effect on the rate of maturation it turns out that no 
correlations (p = 0,620), it is possible there are some other factors 
that affects to maturation rate. However, there is a negative 
correlation (correlation coefficient-0,386) between the age with the 
rate of fertilization (p = 0,035) so that it can be said that the lower 
fertilization rate on increased age, it was certainly in accordance 
with several other studies which stated that the age factor affects the 
level of fertilization [6, 13, 15, 41]. 
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From the recent studies stated that to assess the quality of oocytes 
has been widely proposed to conduct the examination of 
biochemical molecules as a predictor, however, the morphology of 
the oocyte seems to still a method that is popular to determine 
oocyte competent [47]. Although there was in fact, the involvement 
of GDF-9 and BMP-15 in follikulogenesis, steroid genesis and 
maturation of oocytes, but the concentration of GDF-9 and BMP-15 
in follicular fluid or serum individually cannot be used as a predictor 
of development or oocytes competent. 
CONCLUSION 
There were abnormal distribution and no correlation between levels 
of GDF-9 serum and follicular fluid. No correlations between levels 
of GDF-9 serum-FF and BMP-15-FF, and maturation rates and 
fertilization rates. There was negative correlation between BMP-15 
serum and maturation rates. GDF-9 and BMP-15 serum and follicular 
fluid cannot predict oocyte quality. 
This study indicates that GDF-9 and BMP-15 were not the only factor 
that affects to maturation rate and fertilization rate. It is 
recommended for further research to assess the factors that play a 
role of the development and quality of oocytes. 
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